Stimulation of host resistance to metastatic tumors by macrophage activating agents encapsulated in liposomes.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use; D000818:Animals; D003602:Cytotoxicity, Immunologic; D007113:Immunity, Innate; D008081:Liposomes; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology*; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009362:Neoplasm Metastasis / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000188:drug therapy
D008081:Liposomes; D000119:Acetylmuramyl-Alanyl-Isoglutamine